Gradient Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
3,534
-10
-0.3% -$875 ﹤0.01% 402
2026
Q1
$302K Buy
3,544
+46
+1% +$4.1K ﹤0.01% 377
2025
Q4
$276K Buy
3,498
+204
+6% +$16K ﹤0.01% 319
2025
Q3
$263K Hold
3,294
﹤0.01% 344
2025
Q2
$299K Sell
3,294
-76
-2% -$6.94K 0.01% 320
2025
Q1
$316K Buy
3,370
+299
+10% +$26.8K 0.01% 277
2024
Q4
$279K Sell
3,071
-101
-3% -$9.64K 0.01% 266
2024
Q3
$329K Buy
3,172
+2,506
+376% +$255K 0.01% 256
2024
Q2
$64.6K Buy
666
+400
+150% +$36.9K ﹤0.01% 455
2024
Q1
$24K Sell
266
-650
-71% -$55.1K ﹤0.01% 517
2023
Q4
$73K Buy
916
+100
+12% +$7.52K ﹤0.01% 472
2023
Q3
$58K Buy
816
+192
+31% +$14.4K ﹤0.01% 474
2023
Q2
$48.1K Buy
624
+133
+27% +$10.3K ﹤0.01% 511
2023
Q1
$36.9K Buy
491
+9
+2% +$669 ﹤0.01% 546
2022
Q4
$38K Buy
482
+56
+13% +$4.2K ﹤0.01% 558
2022
Q3
$30K Buy
426
+25
+6% +$1.96K ﹤0.01% 578
2022
Q2
$32K Hold
401
﹤0.01% 553
2022
Q1
$30K Hold
401
﹤0.01% 565
2021
Q4
$34K Hold
401
﹤0.01% 558
2021
Q3
$30K Sell
401
-80
-17% -$6.35K ﹤0.01% 569
2021
Q2
$39K Buy
481
+11
+2% +$899 ﹤0.01% 505
2021
Q1
$37K Sell
470
-400
-46% -$31.4K ﹤0.01% 502
2020
Q4
$67K Hold
870
﹤0.01% 359
2020
Q3
$67K Buy
870
+266
+44% +$20.3K ﹤0.01% 362
2020
Q2
$44K Hold
604
﹤0.01% 400
2020
Q1
$40K Hold
604
﹤0.01% 383
2019
Q4
$42K Sell
604
-2
-0.3% -$136 ﹤0.01% 435
2019
Q3
$45K Hold
606
﹤0.01% 407
2019
Q2
$43K Sell
606
-201
-25% -$14.3K ﹤0.01% 401
2019
Q1
$55K Sell
807
-4
-0.5% -$258 ﹤0.01% 325
2018
Q4
$48K Sell
811
-13
-2% -$813 ﹤0.01% 344
2018
Q3
$55K Sell
824
-197
-19% -$13.1K ﹤0.01% 345
2018
Q2
$66K Sell
1,021
-665
-39% -$43.5K ﹤0.01% 305
2018
Q1
$121K Sell
1,686
-104,482
-98% -$7.52M 0.01% 264
2017
Q4
$8.01M Buy
106,168
+6,478
+6% +$473K 0.46% 51
2017
Q3
$7.26M Buy
99,690
+4,374
+5% +$315K 0.46% 50
2017
Q2
$7.07M Buy
95,316
+4,874
+5% +$362K 0.5% 39
2017
Q1
$6.62M Buy
90,442
+90,032
+21,959% +$6.3M 0.51% 35
2016
Q4
$27K Sell
410
-647
-61% -$44.4K ﹤0.01% 326
2016
Q3
$78K Buy
1,057
+657
+164% +$48.6K 0.01% 225
2016
Q2
$29K Hold
400
﹤0.01% 312
2016
Q1
$28K Sell
400
-1,586
-80% -$106K ﹤0.01% 310
2015
Q4
$132K Sell
1,986
-104
-5% -$6.92K 0.02% 191
2015
Q3
$133K Buy
2,090
+1
+0% +$65 0.02% 182
2015
Q2
$137K Buy
2,089
+1,459
+232% +$99K 0.02% 185
2015
Q1
$44K Buy
+630
New +$43.5K 0.01% 257
2014
Q2
Sell
-200
Closed -$13K 510
2014
Q1
$13K Buy
+200
New +$12.6K ﹤0.01% 323
2013
Q3
Sell
-10
Closed -$1K 505
2013
Q2
$1K Buy
+10
New +$594 ﹤0.01% 391

Other funds holding CL

Gradient Investments's CL Position: Q2 2026 in Review

Gradient Investments reduced its Colgate-Palmolive (CL) stake by 0.28% in Q2 2026, selling an estimated $875 and leaving 3,534 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Gradient Investments first reported a position in CL in Q2 2013 and has held it in 48 quarters since. The position peaked at $8.01M in Q4 2017. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Gradient Investments held 3,534 shares of Colgate-Palmolive worth $324K as of Q2 2026.
  • Gradient Investments sold 10 Colgate-Palmolive shares in Q2 2026, an estimated $875.
  • Colgate-Palmolive made up ﹤0.01% of Gradient Investments's portfolio in Q2 2026, its #402 holding.
  • Gradient Investments first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 48 quarters since.
  • Gradient Investments's Colgate-Palmolive position peaked at $8.01M in Q4 2017.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.